[1]钱丽,华海清△.华海清教授运用中药治疗索拉非尼所致腹泻的经验[J].西部中医药,2013,26(07):40-41.
　QIAN Li,HUA Haiqing.The Experience of Professor HUA Haiqing Using TCM to Diarrhea Induced by Sorafenib Tosylate[J].Western Journal of Traditional Chinese Medicine,2013,26(07):40-41.
点击复制

华海清教授运用中药治疗索拉非尼所致腹泻的经验
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年07期
页码:
40-41
栏目:
出版日期:
2013-07-15

文章信息/Info

Title:
The Experience of Professor HUA Haiqing Using TCM to Diarrhea Induced by Sorafenib Tosylate
文章编号:
1004-6852(2013)07-0040-02
作者:
钱丽1，华海清2△
1 南京中医药大学第一临床医学院，江苏 南京 210000； 2 解放军八一医院全军肿瘤中心肿瘤内科
Author(s):
QIAN Li1, HUA Haiqing2△
1 The First Medical School of Nanjing University of Chinese Medicine, Nanjing 210000, China; 2 Department of Oncology in Tumor Center of 81 Military Hospital
关键词:
原发性肝癌; 索拉非尼; 腹泻; 中医药治疗
Keywords:
primary liver cancer;  sorafenib tosylate;  diarrhea;  TCM therapy
分类号:
R249
文献标志码:
A
摘要:
总结华海清教授运用中药治疗索拉非尼所致腹泻的临床经验，华教授认为该病虽病位在肠，但病机当责之于脾，治疗时应兼顾对原发肿瘤的治疗，为相关研究提供借鉴。
Abstract:
Professor HUA Haiqing′s clinical experiences of using TCM to diarrhea which was induced by sorafenib tosylate were summarized, professor Hua thought that the location was at the intestine, but the pathogenesis was the spleen we should consider the treatment for primary cancer, in order to provide evidence for related study.

相似文献/References:

[1]佘彬,陈雁,张瑞明.张瑞明教授治疗原发性肝癌临床经验初探[J].西部中医药,2018,31(01):30.
　SHE Bin,CHEN Yan,ZHANG Ruiming.Exploration into Professor Zhang Ruiming′s Clinical Experience of Treating Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(07):30.
[2]吴文卓,贺松其△.五运六气禀赋与原发性肝癌的相关性[J].西部中医药,2018,31(11):65.
　WU Wenzhuo,HE Songqi.The Correlation between Primary Liver Carcinoma and Natural Endowment of Five Movements and Six Climates[J].Western Journal of Traditional Chinese Medicine,2018,31(07):65.
[3]陈一贞,陈闯.原发性肝癌中医证型客观化研究进展[J].西部中医药,2023,36(02):146.[doi:10.12174/j.issn.2096-9600.2023.02.34]
　CHEN Yizhen,CHEN Chuang.Research Progress in TCM Syndromes Objectification of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(07):146.[doi:10.12174/j.issn.2096-9600.2023.02.34]
[4]苏晓鹏,晏军,张潞潞,等.从阳虚体质探讨原发性肝癌的防治[J].西部中医药,2023,36(05):43.[doi:10.12174/j.issn.2096-9600.2023.05.09]
　SU Xiaopeng,YAN Jun,ZHANG Lulu,et al.Discussion on the Prevention and Treatment of Primary Liver Cancer from Yang Deficiency Constitution[J].Western Journal of Traditional Chinese Medicine,2023,36(07):43.[doi:10.12174/j.issn.2096-9600.2023.05.09]
[5]孙阳,李松哲,孙悦,等.贞术消积汤治疗原发性肝癌组方浅析[J].西部中医药,2023,36(07):72.[doi:10.12174/j.issn.2096-9600.2023.07.17]
　SUN Yang,LI Songzhe,SUN Yue,et al.Brief Analysis of Zhenzhu Xiaoji Tang in the Treatment of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(07):72.[doi:10.12174/j.issn.2096-9600.2023.07.17]

备注/Memo

备注/Memo:
收稿日期：2012-12-18 作者简介：钱丽(1988—)，女，硕士学位。研究方向：肿瘤疾病的中西医结合诊治。 △通讯作者：华海清(1961—)，男，博士后，主任医师。研究方向：肿瘤疾病的中西医结合诊治。
更新日期/Last Update: 2013-07-15